Sign in

Maureen Dubreuil, MD MSc

@spondymd.bsky.social
259 followers 266 following 102 posts

Spondyloarthritis-focused Rheumatologist Boston U School of Med | VA Boston www.bumc.bu.edu/camed/profile/maure…

PostsRepliesMedia
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 04/09/2026
🔊 On behalf of SPARTAN, Dr. Abhijeet Danve and I co-led the *first* North American recommendations for referral of adults suspected of having Axial Spondyloarthritis to a Rheumatologist. Please share widely! acrjournals.onlinelibrary.wiley.com/share/VTKIEP... @spartanrheum.bsky.social
041
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 29/08/2026
020
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 22/07/2026
I brought a bell from my (late) grandmother's collection to keep presenters on time at our Rheum Research Retreat today. We heard from 29 researchers about the incredible work being done in our section! @bu-bmc-rheum.bsky.social
030
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 14/07/2026
North American Spine Society developed guidelines for coverage of SIJ Injections and RFA, including applications in spondyloarthritis. It was privilege to work on this project! Read the guidelines and provide feedback here: www.spine.org/Portals/0/as...
031
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 25/06/2026
The 2026 ACR Axial Spondyloarthritis guideline summary is here! It has been a privilege to work on this project. rheumatology.org/axial-spondy...
rheumatology.org
Axial Spondyloarthritis Clinical Practice Guidelines | American College of Rheumatology
Read American College of Rheumatology recommendations for the treatment of axial spondyloarthritis.
020
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 29/04/2026
The average person with axial spondyloarthritis has back pain without a diagnosis for *over 6 years*. This needs to change! Thanks to @spartanrheum.bsky.social and #PANLAR2026 for the opportunity to highlight this in the pre-congress symposium.
040
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 20/02/2026
Funding rates for R01s decreased in 2025 for applicants from all career stages. grants.nih.gov/news-events/...
010
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 18/01/2026
Scenes from CAThens @rheumcat.bsky.social
040
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 02/01/2026
🐎I just learned of this interesting treatment possibility for #axSpA: HIPPOTHERAPY! A simulator mimics movement of a horse. This makes sense bc of the lumbar spine & hip mobility that riding requires. My relative with axSpA said "Should I start horsing around?!" www.tandfonline.com/doi/full/10....
tandfonline.com
020
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 25/11/2025
It is an honor to continue serving on the board of SPARTAN alongside this esteemed group. We met last week to discuss the direction of #spondyloarthritis research and the future looks bright!💡 @spartanrheum.bsky.social @nigil-haroon.bsky.social @rheumcat.bsky.social
11 researchers in spondyloarthritis standing in front of a brick wall
020
Reposted by Maureen Dubreuil, MD MSc
Jose Antonio Meade @josemeade.bsky.social · 14/10/2025
🧵 New study alert! 💊 Does early TNF inhibitor (TNFi) therapy reduce chronic opioid use in axial spondyloarthritis (axSpA)? 👉 We looked at real-world US data to find out. 📄 Arthritis Care & Research, 2025 🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/... @rheumcat.bsky.social
252
Reposted by Maureen Dubreuil, MD MSc
Rheum Cat @rheumcat.bsky.social · 22/09/2025
Our paper looking at annual prescription rates of opioids 💊 vs NSAIDs 💊and TNF inhibitors 💉for people with axial spondyloarthritis in the US & UK is now out @acr-journals.bsky.social pubmed.ncbi.nlm.nih.gov/40977482/ @degirmenciberk2.bsky.social is preparing a visual abstract, so stay tuned
pubmed.ncbi.nlm.nih.gov
Trends in Opioid Prescriptions in Individuals with Axial Spondyloarthritis in the US and UK in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims Data - PubMed
Opioid prescriptions rates remained stable over time in the UK, while they slightly decreased in the US as TNFi uptake increased. These trends may reflect a US nationwide change in guidance for opioid...
0123
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 23/09/2025
We at BU Rheum had the pleasure of learning from Drs. Divya Shankar and Mari-Lynn Drainone to speak today on Implementation Science. sites.bu.edu/ciis/ @bu-bmc-rheum.bsky.social
sites.bu.edu
CIIS
132
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 12/09/2025
We found that adults with axSpA or PsA had ⬇️ odds of hip/knee replacement with use ofTNFi, non-TNFi biologics or DMARDs as compared to NSAIDs. Odds w/ JAK inhib was also lower but not statistically significant. Use this info in shared decision-making!
061
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 11/09/2025
Veterans I care for at VA Boston showed me so much love today with tasty treats! Incredible tomatoes, spaghetti & meatballs and homemade BBQ sauce! @vaboston.bsky.social
091
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 17/06/2025
This is critically important to our understanding of SpA!
020
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 08/05/2025
The SPARTAN Review Course is on! Dr. Aki Nakamura presented on the pathogenesis of axial spondyloarthritis, highlighting new science around HLA-B27, arthritogenic peptides and mechanisms of disease independent of HLA-B27. deptmed.queensu.ca/index.php/pe...
162
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 06/05/2025
💫As part of our T32 lecture series @bu-bmc-rheum.bsky.social welcomed Drs. Sarah Bagley (GIM) and Vanessa Xanthakis (Preventive Med) to discuss LIFE HACKS FOR BUSY RESEARCHERS. Highlights here. Do you have any tips to share? www.bumc.bu.edu/rheumatology...
A graphic describing how to think about an invitation for a new role or project, and strategies for productivity.
022
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 30/04/2025
Today we learned from osteoporosis expert Dr. Alan Malabanan about management of patients at very high risk for fracture. @alanmalabanan.bsky.social www.bumc.bu.edu/medicine/pro...
bumc.bu.edu
Alan Malabanan | Medicine
332
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 28/04/2025
🌏The 7th Annual Global Spondyloarthritis Summit is May 2nd & 3rd! Enjoy interactive activities, rooms, networking, gamification, exercise and yoga classes, poster hall, exhibit hall, swag bags, social media wall and more. spondyloarthritissummit2025.vfairs.com
spondyloarthritissummit2025.vfairs.com
SAA Global Spondyloarthritis Summit 2025
010
Reposted by Maureen Dubreuil, MD MSc
The Journal of Rheumatology @jrheumatol.bsky.social · 25/04/2025
Editor's Picks Spotlight Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis with Drs. Renato Ferrandiz-Espadin, Jean W. Liew and Maureen Dubreuil @renatoferrandiz.bsky.social @rheumcat.bsky.social @spondymd.bsky.social 📖 doi.org/10.3899/jrhe... 📽️ youtu.be/jXAe-dlbxsc
youtu.be
Editor's Picks Spotlight: Disparities in Time to Diagnosis of r-axSpA
YouTube video by The Journal of Rheumatology
033
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 09/04/2025
💡 We recently had the pleasure of learning from my colleague, Dr. Monica Crespo-Bosque, who discussed Treatment of Arthritis in Lupus. www.bumc.bu.edu/camed/profil...
bumc.bu.edu
Monica Crespo-Bosque | Chobanian & Avedisian School of Medicine
110
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 03/04/2025
Congrats to Deepak Kumar sites.bu.edu/kumarlab/ who found that earlier PT and >12 sessions were associated with lower risk of future intra-articular therapy use in people w/ knee OA. doi.org/10.1002/art....
062
Reposted by Maureen Dubreuil, MD MSc
Mathieu Choufani @mchoufani.bsky.social · 01/04/2025
Excited to share our latest publication on demographic & geographic diversity in axial spondyloarthritis drug trials! We analyzed 59 trials (16,000+ participants) since 2000. Big thanks to the team @wissamghusn.bsky.social @spondymd.bsky.social @joergermann pubmed.ncbi.nlm.nih.gov/40089303/
pubmed.ncbi.nlm.nih.gov
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region - PubMed
The enrollment of women in axSpA drug trials largely reflects disease demographics. Race and ethnicity reporting has improved over time. While participation of Asian, American Indian/Alaska Native and...
141
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 01/04/2025
We found that diagnostic delay in axial spondyloarthritis was 21% longer (7 months) among people with a social need, using an accelerated failure time model. @jrheumatol.bsky.social @renatoferrandiz.bsky.social www.jrheum.org/content/52/4...
jrheum.org
Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis
Objective Radiographic axial spondyloarthritis (r-axSpA) has a 7-year average diagnostic delay. Although the effects of sex or gender on time to diagnosis have been evaluated, the role of social deter...
0116
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 09/03/2025
Girls just want to have fun-ding for scientific research
000
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 05/03/2025
We had the pleasure of learning from Dr. Robert John Fontana today about liver injury related to DMARDs and other rheum meds #rheumsky www.michiganmedicine.org/profile/3966...
michiganmedicine.org
Robert J. Fontana
141
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 20/02/2025
Our study was covered by Healio: TNFi were associated with 29% lower odds of fracture relative to NSAIDs in axSpA! www.healio.com/news/rheumat...
healio.com
TNF inhibitors may reduce fracture risk 29% vs NSAIDs in axial spondyloarthritis
TNF inhibitors for the treatment of axial spondyloarthritis may decrease the risk for hip or spine fracture by as much as 29% compared with NSAIDs, according to data published in Arthritis & Rheum...
041
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 16/02/2025
I just came across *3 messages* I sent myself in the middle of the night with additional thoughts on a sick person I recently cared for. #Rheumsky
020
Reposted by Maureen Dubreuil, MD MSc
American College of Emergency Physicians @acepnation.bsky.social · 04/02/2025
Access to timely health information is critical for emergency care. #MedSky #EMSky #EMedSky
21811
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 28/01/2025
Last week I visited the Anne Frank House- I urge you to visit, too. On this Holocaust Remembrance Day and every day, we stand against hatred.
020
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 24/01/2025
SPARTAN's call for trainee abstracts in #spondyloarthritis is out. Due Feb 28. Annual Meeting May 9 & 10 in Toronto. (review course May 8) spartangroup.org/call-for-202...
010
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 24/01/2025
SPARTAN Announced $10,000 Mentored Fellowship Award for rheumatology trainees to fund #spondyloarthritis research projects. Awards announced at the SPARTAN. Membership not required. Due Feb 28. spartangroup.org/mentored-fel...
000
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 24/01/2025
SPARTAN announced a $25,000 Early Career Investigator Award for members. Due Feb 28. t.co/k232lhj2uw
t.co
https://spartangroup.org/early-career-investigator-award/
000
Reposted by Maureen Dubreuil, MD MSc
Amy Feldman @amyfeldman7.bsky.social · 22/01/2025
If you’ve been directly impacted by a pause or cancellation of an NIH study session, we @forbes.com would like to talk to you
7527501600
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 23/01/2025
If not immediately reversed, Trump's effective shut down of the NIH is going to cause permanent damage to the reputation of US as a leader in science. www.science.org/content/arti...
science.org
Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring
Researchers facing
063
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 22/01/2025
It was a pleasure to attend the ASAS Annual Meeting in the historic city of Maastricht, especially with my SPARTAN colleagues! Congratulations to ASAS on their 30th birthday!!🎉
161
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 18/12/2024
We are celebrating winter holidays with all the treats!! 😍 @bu-bmc-rheum.bsky.social
280
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 18/12/2024
⬇️🦴 We found that TNF inhibitor use in axSpA was associated with 29% lower odds of fracture (relative to NSAIDs). Check out our paper in A&R: acrjournals.onlinelibrary.wiley.com/doi/abs/10.1... Congrats to Devin Driscoll, Navya George, @rheumcat.bsky.social and collaborators!
182
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 13/12/2024
Congratulations to Drs. Mohamad Bittar and Atul Deodhar for this *outstanding* review of axial spondyloarthritis. Bookmark this for a read!
171
Maureen Dubreuil, MD MSc @spondymd.bsky.social · 13/12/2024
It's an honor to serve alongside this illustrious crew on the SPARTAN (Spondyloarthritis Research and Treatment Network) board. Our retreat was a great success! Spartangroup.org
1101